U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07058701) titled 'Serum Instant Anti-Redness Efficacy Clinical Study' on June 18.
Brief Summary: This study is a mono-centric, om-site use, random half-face application, blank control study. 64 female adult subjects will be enrolled and divided into 2 groups in the study, recruited according to inclusion and non-inclusion criteria listed above. At least 30 subjects for each group should complete the test in this 1 visit study.
Study Start Date: April 22, 2024
Study Type: INTERVENTIONAL
Condition:
Female
Redness
Intervention:
OTHER: Investigational Serum, Standard Cleanser
Mode of Group Serum application : On-site single use
Standard cleanser ...